Neuroinformatics

A new tool for studying the brain

Floyd E. Bloom, John Morrison, Warren G. Young

Research output: Contribution to journalReview article

3 Citations (Scopus)

Abstract

Background: Central nervous system diseases constitute a major target for drug development. Genes expressed by the nervous system may represent half or more of the mammalian genome, with literally tens of thousands of gene products. Methods: Better methods are therefore required to accelerate the pace of mapping gene expression patterns in the mouse brain and to evaluate the progressive phenotypic changes in genetic models of human brain diseases. Conclusions: Recent studies of mouse models of Amyotrophic Lateral Sclerosis and Alzheimer's disease illustrate how such data could be used for drug development. Since these two diseases - especially Alzheimer's Disease - entail disordered behavior, cognition and emotions, the framework and the methodology described in this article might in the future find applications in research on affective disorders.

Original languageEnglish (US)
Pages (from-to)133-138
Number of pages6
JournalJournal of Affective Disorders
Volume92
Issue number1
DOIs
StatePublished - May 1 2006
Externally publishedYes

Fingerprint

Alzheimer Disease
Central Nervous System Diseases
Genetic Models
Amyotrophic Lateral Sclerosis
Brain
Brain Diseases
Mood Disorders
Pharmaceutical Preparations
Cognition
Nervous System
Genes
Emotions
Genome
Gene Expression
Research

Keywords

  • Alzheimer's disease
  • Cellular pathophysiology
  • Neuroinformatics

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Behavioral Neuroscience
  • Biological Psychiatry
  • Neurology
  • Psychology(all)

Cite this

Neuroinformatics : A new tool for studying the brain. / Bloom, Floyd E.; Morrison, John; Young, Warren G.

In: Journal of Affective Disorders, Vol. 92, No. 1, 01.05.2006, p. 133-138.

Research output: Contribution to journalReview article

Bloom, Floyd E. ; Morrison, John ; Young, Warren G. / Neuroinformatics : A new tool for studying the brain. In: Journal of Affective Disorders. 2006 ; Vol. 92, No. 1. pp. 133-138.
@article{57827640cfa347d88644345262c4a74b,
title = "Neuroinformatics: A new tool for studying the brain",
abstract = "Background: Central nervous system diseases constitute a major target for drug development. Genes expressed by the nervous system may represent half or more of the mammalian genome, with literally tens of thousands of gene products. Methods: Better methods are therefore required to accelerate the pace of mapping gene expression patterns in the mouse brain and to evaluate the progressive phenotypic changes in genetic models of human brain diseases. Conclusions: Recent studies of mouse models of Amyotrophic Lateral Sclerosis and Alzheimer's disease illustrate how such data could be used for drug development. Since these two diseases - especially Alzheimer's Disease - entail disordered behavior, cognition and emotions, the framework and the methodology described in this article might in the future find applications in research on affective disorders.",
keywords = "Alzheimer's disease, Cellular pathophysiology, Neuroinformatics",
author = "Bloom, {Floyd E.} and John Morrison and Young, {Warren G.}",
year = "2006",
month = "5",
day = "1",
doi = "10.1016/j.jad.2005.12.043",
language = "English (US)",
volume = "92",
pages = "133--138",
journal = "Journal of Affective Disorders",
issn = "0165-0327",
publisher = "Elsevier",
number = "1",

}

TY - JOUR

T1 - Neuroinformatics

T2 - A new tool for studying the brain

AU - Bloom, Floyd E.

AU - Morrison, John

AU - Young, Warren G.

PY - 2006/5/1

Y1 - 2006/5/1

N2 - Background: Central nervous system diseases constitute a major target for drug development. Genes expressed by the nervous system may represent half or more of the mammalian genome, with literally tens of thousands of gene products. Methods: Better methods are therefore required to accelerate the pace of mapping gene expression patterns in the mouse brain and to evaluate the progressive phenotypic changes in genetic models of human brain diseases. Conclusions: Recent studies of mouse models of Amyotrophic Lateral Sclerosis and Alzheimer's disease illustrate how such data could be used for drug development. Since these two diseases - especially Alzheimer's Disease - entail disordered behavior, cognition and emotions, the framework and the methodology described in this article might in the future find applications in research on affective disorders.

AB - Background: Central nervous system diseases constitute a major target for drug development. Genes expressed by the nervous system may represent half or more of the mammalian genome, with literally tens of thousands of gene products. Methods: Better methods are therefore required to accelerate the pace of mapping gene expression patterns in the mouse brain and to evaluate the progressive phenotypic changes in genetic models of human brain diseases. Conclusions: Recent studies of mouse models of Amyotrophic Lateral Sclerosis and Alzheimer's disease illustrate how such data could be used for drug development. Since these two diseases - especially Alzheimer's Disease - entail disordered behavior, cognition and emotions, the framework and the methodology described in this article might in the future find applications in research on affective disorders.

KW - Alzheimer's disease

KW - Cellular pathophysiology

KW - Neuroinformatics

UR - http://www.scopus.com/inward/record.url?scp=33646363757&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33646363757&partnerID=8YFLogxK

U2 - 10.1016/j.jad.2005.12.043

DO - 10.1016/j.jad.2005.12.043

M3 - Review article

VL - 92

SP - 133

EP - 138

JO - Journal of Affective Disorders

JF - Journal of Affective Disorders

SN - 0165-0327

IS - 1

ER -